Noxafil 300 mg concentrate for solution for infusion, Posaconazole, Posaconazole
MK-5592-127
Phase 2 small_molecule active
Quick answer
Noxafil 300 mg concentrate for solution for infusion, Posaconazole, Posaconazole for Fungal infection is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Fungal infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active